...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Vote - please

Thanks koo.

I'll check out my work and adjust as needed.

Cheers

Toinv

Share
New Message
Please login to post a reply